U.S. Computer-Aided Detection (CAD) Market, by Product Type (Breast CAD, Abdominal CAD, Prostrate CAD, Cardiovascular CAD, Others), by Imaging Modality (Mammography, X-Ray Imaging, MRI, Computed Tomography, Ultrasound, Others) is estimated to be valued at US$ 632.0 Million in 2023 and is expected to exhibit a CAGR of 9.2% during the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights.
Increase in the prevalence of cardiovascular diseases is expected to grow the market over the forecast period. For instance, in June 2021, a data was published by World Health Organization (WHO), according to that cardiovascular diseases (CVDs) are the leading cause of death. An estimated 17.9 million people died from CVDs in 2019, representing 32% of all deaths. Of these deaths, 85% were due to heart attack and stroke.
U.S. Computer-Aided Detection (CAD) Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2019 as "coronavirus disease 2019" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems with regard to the transportation of drugs from one place to another.
COVID-19 positively affected the market as the increasing demand for the detection equipment was increased during the pandemic.
U.S. Computer-Aided Detection (CAD) Market: Key Developments
Increasing launch of products is expected to drive the market over the forecast period. For instance, in March 2023, Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced the full U.S. commercial availability of the Shockwave L6 Peripheral IVL Catheter following clearance by the U.S. Food and Drug Administration (FDA). The Shockwave L6 catheter is purpose-built to modify calcification in otherwise difficult-to-treat lesions in large peripheral vessels, including the iliac and the common femoral arteries.
Browse 27 Market Data Tables and 22 Figures spread through 157 Pages and in-depth TOC on “U.S. Computer-Aided Detection (CAD) Market”- Forecast to 2030, U.S. Computer-Aided Detection (CAD) Market, , by Product Type (Breast CAD, Abdominal CAD, Prostrate CAD, Cardiovascular CAD, Others), by Imaging Modality (Mammography, X-Ray Imaging, MRI, Computed Tomography, Ultrasound, Others)
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/us-computer-aided-detection-cad-market-3292
Key Takeaways of the U.S. Computer-Aided Detection (CAD) Market:
- The U.S. computer-aided detection (CAD) market is expected to exhibit a CAGR of 14.2% during the forecast period due to the increasing inorganic strategies such as acquisitions by the key players. For instance, in February 2023, Abbott, a medical device manufacturing company and Cardiovascular Systems, Inc., a medical device company, announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.
- Among product type, breast CAD segment is estimated to hold a dominant position in the U.S. computer-aided detection (CAD) market over the forecast period.
- Major players operating in the U.S. computer-aided detection (CAD) market include iCAD, Inc., Koninklijke Philips N.V., Holojic, Inc., Carestream Health, Inc., Siemens AG, GE Healthcare, EDDA Technology, Inc., EDDA Technology, Inc., and other prominent players.
